news Usher syndrome: first nonhuman primate model 14 February 2023 | By Izzy Wood (Drug Target Review) US researchers evaluate an experimental gene therapy in the first ever nonhuman primate model for Usher Syndrome.
news Bacteria’s survival strategies against antibiotics 13 February 2023 | By Izzy Wood (Drug Target Review) US researchers investigate how bacteria develop an antibiotic tolerance without mutations.
whitepaper Application note: Agilent XF real time ATP rate assay 13 February 2023 | By Agilent Discover how the Agilent Seahorse XF Real Time ATP rate assay provides a simple robust workflow that can identify metabolic targets for drug discovery
news Therapeutic strategy using p53 induces cancer cell death 13 February 2023 | By Izzy Wood (Drug Target Review) US researchers spotlight how p53, the most frequently mutated tumour suppressor gene, can be activated against cancer cells.
article Latest in lab automation 9 February 2023 | By Izzy Wood (Drug Target Review) In this article Drug Target Review's Izzy Wood highlights three of the latest findings using lab automation techniques and technologies that aid scientists.
news Unlocking the secrets of Strep A virulence 9 February 2023 | By Izzy Wood (Drug Target Review) Australian researchers have uncovered why some forms of Streptococcus A (Strep A) are associated with severe invasive infection.
article Ovarian cancer breakthrough: the potential of rhenium tricarbonyl (TRIP) as a promising anti-tumour drug 8 February 2023 | By Izzy Wood (Drug Target Review) In this exclusive article, Drug Target Review’s Izzy Wood highlights ground-breaking ovarian cancer research, after speaking with Dr Benjamin Neuditschko, from the Institute Krems Bioanalytics at IMC Krems.
news What do cancer cells crave? 7 February 2023 | By Izzy Wood (Drug Target Review) US researchers uncover the amino acid: arginine, that prompts genetic mutations in cancer cells.
news New immunotherapy approach holds promise for ovarian cancer 6 February 2023 | By Izzy Wood (Drug Target Review) A new approach using CAR T-cell therapy is suggested by Swedish researchers as an effective treatment for ovarian cancer.
news Uncovering the first FDA-approved drug for Ebola virus infection 6 February 2023 | By Izzy Wood (Drug Target Review) US scientists have outlined the structure and function of the first FDA approved drug for the Ebola virus.
news What is the link between serotonin and heart valve disease? 3 February 2023 | By Izzy Wood (Drug Target Review) US researchers found that serotonin impacts the mitral valve in the heart which can lead to heart valve disease.
news Experimental antidepressant could also treat alcohol use disorder 3 February 2023 | By Izzy Wood (Drug Target Review) A US pre-clinical study investigating the antidepressant: MAP4343, discovered it reduced alcohol intake in a mouse model of alcoholism.
news Measles virus can develop mutations that cause fatal SSPE 2 February 2023 | By Izzy Wood (Drug Target Review) Japanese researchers find a new mechanism for how the measles virus can cause a rare but fatal neurological disorder: subacute sclerosing panencephalitis (SSPE).
whitepaper Whitepaper: Oncology therapeutics discovery solutions 2 February 2023 | By Cell SIgnaling Technology Streamline oncology therapeutic development with CST® recombinant monoclonal antibodies, ELISA & cellular assay kits, & custom products & services.
news AI tools aid the discovery of super tight-binding antibodies 2 February 2023 | By Izzy Wood (Drug Target Review) An AI strategy developed by US scientists could accelerate the development of new antibody drugs.
